Fishman L, Marsh W R
Neurosurgery. 1984 Jun;14(6):735-6. doi: 10.1227/00006123-198406000-00015.
A case of moxalactam-induced coagulopathy is reported. The authors think that this coagulopathy is caused by an effect on platelet aggregation and not by inhibition of vitamin K-dependent clotting factors. It is recommended that bleeding times be routinely checked preoperatively in patients being treated with moxalactam.